/DISCLAIMER · RESEARCH_COMPOUND

This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.

/SUPER_SHRED
Injectable Blend

Super Shredder

Lipotropic + Metabolic Injectable Formula

/HALF_LIFE
Varies by component (e.g., albuterol ~3–6 hours; B12 may persist for days; others generally hours).
/DELIVERY
Intramuscular injection (IM); dosing schedule per protocol.

/WHAT_IT_IS

High-potency research blend formulated for lipolysis and metabolic support. Composition per mL: L-Carnitine 400 mg, MIC blend 100 mg (methionine/inositol/choline), ATP 50 mg, Albuterol 2 mg, Vitamin B12 1 mg. Pack size: 10 mL × 553 mg/mL per vial, 10 vials total. Note: Includes a systemic β2-agonist (albuterol); use only in controlled research settings with appropriate monitoring (HR/BP).

/USAGE

Investigated for adjunctive support of fat metabolism, energy production, and performance protocols in research models.

/MECHANISM_OF_ACTION

L-Carnitine facilitates mitochondrial long-chain fatty-acid transport; MIC components act as lipotropics supporting hepatic lipid handling and methylation; ATP provides immediate phosphate energy donor in formulations; albuterol (β2-adrenergic agonist) promotes lipolysis and bronchodilation; vitamin B12 supports erythropoiesis and cellular energy metabolism.

Reported Benefits

  • +Supports fatty-acid mobilization and oxidation
  • +Adjunct to weight-management research protocols
  • +May enhance perceived energy and training capacity

Reported Side Effects

  • Injection-site irritation
  • Jitteriness, tremor, palpitations, or tachycardia (albuterol component)
  • Insomnia or anxiety (stimulant effect)
  • Headache, flushing, or GI upset
  • Rare: hypokalemia or blood-pressure changes (β2-agonist class)

/STACKED_WITH

Dietary and exercise interventions in study designCJC-1295 (no DAC) or Ipamorelin (GH-axis research)AOD-9604 or HGH Frag 176-191 (lipolysis-focused studies)

/RESEARCH_NOTES

Screen for cardiovascular sensitivity before inclusion due to β2-agonist. Monitor HR, BP, electrolytes (especially potassium), and sleep quality. Avoid concurrent stimulants in study arms unless explicitly controlled.

/RELATED

/TRACK_THIS

Browse all 89 in the app.

MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.

Last reviewed: 2026-06-04 · Reference only. Not medical advice. Consult a qualified physician.